Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- PMID: 32074550
- DOI: 10.5582/bst.2020.01047
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Abstract
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.
Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; chloroquine; pneumonia.
Comment in
-
Chloroquine hype is derailing the search for coronavirus treatments.Nature. 2020 Apr;580(7805):573. doi: 10.1038/d41586-020-01165-3. Nature. 2020. PMID: 32332911 No abstract available.
Similar articles
-
[Chloroquine phosphate: therapeutic drug for COVID-19].Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):586-594. doi: 10.12122/j.issn.1673-4254.2020.04.22. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 32895128 Free PMC article. Clinical Trial. Chinese.
-
[Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)].Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020 Apr 22;32(2):119-122. doi: 10.16250/j.32.1374.2020092. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020. PMID: 32458599 Review. Chinese.
-
Chloroquine and its derivatives in the management of COVID-19: A scoping review.Biomedica. 2020 Oct 30;40(Supl. 2):80-95. doi: 10.7705/biomedica.5478. Biomedica. 2020. PMID: 33152192 Free PMC article. English, Spanish.
-
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.Molecules. 2020 Apr 16;25(8):1834. doi: 10.3390/molecules25081834. Molecules. 2020. PMID: 32316270 Free PMC article.
-
Trial of Chloroquines in the Treatment of COVID-19 and Its Research Progress in Forensic Toxicology.Fa Yi Xue Za Zhi. 2020 Apr;36(2):157-163. doi: 10.12116/j.issn.1004-5619.2020.02.002. Epub 2020 Mar 25. Fa Yi Xue Za Zhi. 2020. PMID: 32212512 Review. Chinese, English.
Cited by
-
Chitosan-Zinc-Ligated Hydroxychloroquine: Molecular Docking, Synthesis, Characterization, and Trypanocidal Activity against Trypanosoma evansi.Polymers (Basel). 2024 Sep 30;16(19):2777. doi: 10.3390/polym16192777. Polymers (Basel). 2024. PMID: 39408487 Free PMC article.
-
N-alkylation of amines for the synthesis of potential antiviral agents: A structural modification approach.Heliyon. 2024 Sep 27;10(19):e38587. doi: 10.1016/j.heliyon.2024.e38587. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39397970 Free PMC article.
-
Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19.Heliyon. 2024 Aug 28;10(17):e37098. doi: 10.1016/j.heliyon.2024.e37098. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281655 Free PMC article. Review.
-
Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection.Mol Biotechnol. 2024 Sep 13. doi: 10.1007/s12033-024-01277-5. Online ahead of print. Mol Biotechnol. 2024. PMID: 39266903 Review.
-
Cyanobacterial and microalgae polymers: antiviral activity and applications.Braz J Microbiol. 2024 Jul 15. doi: 10.1007/s42770-024-01452-5. Online ahead of print. Braz J Microbiol. 2024. PMID: 39008244 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
